These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Life-threatening thrombocytosis following GCSF treatment in a case of clozapine-induced agranulocytosis. Dihingia S, Deka K, Bhuyan D, Mondal SK. Gen Hosp Psychiatry; 2012; 34(3):320.e1-2. PubMed ID: 22018773 [Abstract] [Full Text] [Related]
3. Zero Eosinophil Count as a Predictor of Clozapine-Associated Late-Onset Agranulocytosis: A Case Report. Yang HN, Ho PS, Tseng YT, Liang CS. J Clin Psychopharmacol; 2018 Oct; 38(5):531-532. PubMed ID: 30113930 [No Abstract] [Full Text] [Related]
4. Should the clozapine protocol be obeyed? Drew L. Aust N Z J Psychiatry; 2011 Sep; 45(9):790. PubMed ID: 21668297 [No Abstract] [Full Text] [Related]
8. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis? Verbelen M, Lewis CM. Pharmacogenomics; 2015 Sep; 16(9):915-7. PubMed ID: 26122865 [No Abstract] [Full Text] [Related]
9. White blood cell monitoring during long-term clozapine treatment. Cohen D, Monden M. Am J Psychiatry; 2013 Apr; 170(4):366-9. PubMed ID: 23545791 [Abstract] [Full Text] [Related]
16. Clozapine-Associated Neutropenia and Agranulocytosis. Andres E, Mourot-Cottet R. J Clin Psychopharmacol; 2017 Dec 27; 37(6):749-750. PubMed ID: 29040154 [No Abstract] [Full Text] [Related]
17. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis. Hazewinkel AW, Bogers JP, Giltay EJ. Gen Hosp Psychiatry; 2013 Dec 27; 35(5):576.e11-2. PubMed ID: 23395419 [Abstract] [Full Text] [Related]